News & Updates
The GLP-1 space moves faster than any other prescription category. A new pill formulation, an FDA approval, a Medicare policy shift — each can change affordability within weeks. Our news coverage focuses on what actually affects patients: the latest GLP-1 roundup, the Foundayo (orforglipron) FDA approval, and regulatory shifts affecting compounded access.
Compounded Semaglutide: Still Legal in 2026?
The FDA's April 30 proposed rule, the June 30 comment deadline, and what actually changed for 503A compounding. A precise…
Latest in News & Updates
GLP-1 in 2026: 5 Big Changes Coming Soon
A new pill, a far more powerful drug in trials, a Medicare pilot, a tightening line on compounding. The GLP-1…
Compounded Semaglutide from $147/month
LegitScript-certified · 503A US pharmacy · 1-2 day shipping · Available in 48 states